TD Cowen Maintains Hold on 10x Genomics, Raises Price Target to $70
Benzinga Newsdesk 4 weeks ago
Analyst RatingsNewsPrice Target
TD Cowen analyst Dan Brennan maintains 10x Genomics (NASDAQ:TXG) with a Hold and raises the price target from $47 to $70.
TD Cowen analyst Dan Brennan maintains 10x Genomics (NASDAQ:TXG) with a Hold and raises the price target from $47 to $70.